Skye Bioscience (SKYE) Cash & Current Investments (2012 - 2026)
Skye Bioscience (SKYE) posted Cash & Current Investments of $10.06 million for Q2 2026, down 79.3% from $48.59 million a year earlier and down 41.2% from the prior quarter.
Powered by 
Analysis
Skye Bioscience (SKYE) Cash & Current Investments (2012 - 2026) Analysis & Trends
At the end of FY2025, Skye Bioscience's Cash & Current Investments came in at $25.74 million, down 62.4% from FY2024.
- Annual Cash & Current Investments shows a five-year compound annual growth rate of 59.8% (FY2020 to FY2025).
- In prior years, Skye Bioscience's Cash & Current Investments was $68.42 million in FY2024, $1.26 million in FY2023 (+1.0%), $1.24 million in FY2022 (-86.1%) and $8.98 million in FY2021 (+263.8%).
- The Q2 2026 figure stands as the lowest quarterly Cash & Current Investments since Q4 2023.
- On a year-over-year basis, Cash & Current Investments has declined in each of the last six quarters, with an average decline of 54.0% over the last six quarters.
- The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q4 2021, with growth of 263.8%; the weakest was Q3 2022, with a decline of 96.3%.
- According to Business Quant data, Cash & Current Investments for the three prior quarters was $17.11 million (Q1 2026), $25.74 million (Q4 2025) and $35.31 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Skye Bioscience | 6.77 Mn | -81.46 Mn | - | 10.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.06 Mn |
| Mar 31, 2026 | 17.11 Mn |
| Dec 31, 2025 | 25.74 Mn |
| Sep 30, 2025 | 35.31 Mn |
| Jun 30, 2025 | 48.59 Mn |
| Mar 31, 2025 | 59.22 Mn |
| Dec 31, 2024 | 68.42 Mn |
| Sep 30, 2024 | 67.41 Mn |
| Jun 30, 2024 | 74.12 Mn |
| Mar 31, 2024 | 83.34 Mn |
| Dec 31, 2023 | 1.26 Mn |
| Sep 30, 2023 | 5.13 Mn |
| Jun 30, 2023 | 553,443.00 |
| Mar 31, 2023 | 2.67 Mn |
| Dec 31, 2022 | 1.24 Mn |
| Sep 30, 2022 | 415,389.00 |
| Jun 30, 2022 | 2.93 Mn |
| Mar 31, 2022 | 6.01 Mn |
| Dec 31, 2021 | 8.98 Mn |
| Sep 30, 2021 | 11.09 Mn |
API Access
Skye Bioscience Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=SKYE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "SKYE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=SKYE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();